Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS

Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 ·Status: COMPLETED

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

NCT05866458 ·Status: RECRUITING

Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)

NCT00500383 ·Status: COMPLETED

Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer

NCT04478669 ·Status: COMPLETED

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

NCT03775213 ·Status: COMPLETED ·Phase: NA

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

NCT02347449 ·Status: COMPLETED ·Phase: NA

The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing

NCT04038905 ·Status: UNKNOWN

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

NCT03772197 ·Status: COMPLETED

Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts

NCT04561297 ·Status: COMPLETED ·Phase: NA

Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer

NCT01112254 ·Status: COMPLETED ·Phase: PHASE3

Breast MRI as a Preoperative Tool for DCIS

NCT00605982 ·Status: COMPLETED ·Phase: NA

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer

NCT03669952 ·Status: COMPLETED

Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype

NCT06813456 ·Status: RECRUITING

A Decision Aid for Women With Early Stage Breast Cancer

NCT00201929 ·Status: COMPLETED ·Phase: PHASE3

The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

NCT04916808 ·Status: ACTIVE_NOT_RECRUITING

Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers

NCT03790813 ·Status: UNKNOWN ·Phase: NA

Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer

NCT03568981 ·Status: UNKNOWN

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

NCT04498611 ·Status: COMPLETED ·Phase: NA

Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study

NCT06484725 ·Status: COMPLETED

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS

NCT06217458 ·Status: NOT_YET_RECRUITING ·Phase: NA

Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

NCT03148015 ·Status: COMPLETED

HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program

NCT02616133 ·Status: COMPLETED

Digital Mammography for the Detection and Preoperative Staging of Breast Cancer

NCT01086514 ·Status: COMPLETED ·Phase: NA

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

NCT06111417 ·Status: RECRUITING

Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy

NCT05846997 ·Status: UNKNOWN